David Tucker Sells 704 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP David Tucker sold 704 shares of the company’s stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $107.35, for a total value of $75,574.40. Following the completion of the sale, the executive vice president owned 10,802 shares of the company’s stock, valued at $1,159,594.70. This trade represents a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $103.53 on Friday. The business’s fifty day moving average is $109.22 and its 200 day moving average is $112.95. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $124.43. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.66 and a current ratio of 1.80. The company has a market capitalization of $1.92 billion, a PE ratio of 19.87, a price-to-earnings-growth ratio of 1.44 and a beta of 0.91.

Key Stories Impacting Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
• Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
• Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
• Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
• Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
• Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. TD Cowen restated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. Barclays decreased their price objective on shares of Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a report on Wednesday. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $134.33.

Hedge Funds Weigh In On Addus HomeCare

A number of hedge funds and other institutional investors have recently modified their holdings of ADUS. Capital Research Global Investors grew its stake in Addus HomeCare by 22.3% during the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after acquiring an additional 268,192 shares in the last quarter. Tributary Capital Management LLC boosted its holdings in shares of Addus HomeCare by 114.1% during the 3rd quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock valued at $46,974,000 after purchasing an additional 212,192 shares during the last quarter. Freestone Grove Partners LP grew its position in shares of Addus HomeCare by 5,035.2% during the fourth quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock valued at $14,813,000 after purchasing an additional 135,246 shares in the last quarter. 8 Knots Management LLC purchased a new position in shares of Addus HomeCare during the third quarter valued at about $6,075,000. Finally, TimesSquare Capital Management LLC increased its holdings in shares of Addus HomeCare by 13.9% in the second quarter. TimesSquare Capital Management LLC now owns 394,047 shares of the company’s stock worth $45,390,000 after purchasing an additional 48,207 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.